Abstract
Background
Cancer is one of the most prevalent diseases and is recognized as a global problem that is currently showing a growing trend. Cancer is one of the most stressful circumstances that a person may experience. Given how the mental state of patients with depression and anxiety may have a negative impact on their experience with cancer, this study was conducted with the aim to investigate the prevalence of anxiety and depression in cancer patients in Iran.
Methods
This study was conducted using a systematic review method and based on the guideline Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020). The studies used were searched for via databases, Scopus, Web of Science (WOS), Google Scholar, SID, Magiran, and using keywords related to anxiety, depression, and cancer. After extracting the required data, statistical analysis was performed based on the random model and using the second version of Comprehensive Meta-Analysis Software.
Results
In a review of 24 studies with a sample size of 3225 people, the overall prevalence of depression in cancer patients in Iran was reported to be 50.1% (95% CI: 40.6–59.6). Additionally, in a review of 15 studies with a sample size of 2009, the overall prevalence of anxiety in cancer patients in Iran was reported to be 40.9% (95% CI: 30.9–51.6). The highest reported prevalence of depression in cancer patients in Iran according to the Beck questionnaire is 64.6 (95% CI: 48.2–78.1). Specifically, the highest prevalence of depression was reported in patients with breast cancer with a prevalence of 66 (95% CI: 50.9–78.4). The highest prevalence of anxiety in patients with cancer in Iran according to the Depression, Anxiety, and Stress Scale was 49.2 (95% CI: 18.9–80.1). Comparatively, the highest prevalence of anxiety in patients with breast cancer was reported to be 53.2 (95% CI: 25.8–78.7).
Conclusion
The prevalence of depression and anxiety among cancer patients in Iran, in particular patients with breast cancer, is significantly higher than in other parts of the world. The prevalence found in our study was even higher than the reported number by studies that have examined the disorder globally. Therefore, it is of great urgency for health system policymakers to work to improve the current situation.
Similar content being viewed by others
Data availability
Datasets are available through the corresponding author upon reasonable request.
Abbreviations
- SID :
-
Scientific Information Database
- MESH :
-
Medical Subject Headings
- WoS :
-
Web of Science
- IARC :
-
International Agency for Research on Cancer
- PRISMA :
-
Preferred Reporting Items for Systematic Reviews and Meta-Analysis
- NOS :
-
Newcastle-Ottawa Scale
References
Nikbakhsh N, Moudi S, Abbasian S, Khafri S (2014) Prevalence of depression and anxiety among cancer patients. Caspian J Intern Med 5(3):167
Global Burden of Disease Cancer C, Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, Abdelalim A, Abdoli A, Abdollahpour I et al (2019) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 5(12):1749–1768
Rezapour A, Nargesi S, Mezginejad F, Rashki Kemmak A, Bagherzadeh R (2021) The economic burden of cancer in Iran during 1995–2019: a systematic review. Iran J Public Health 50(1):35–45
Mohammadian M, Salehiniya H, Mohammadian-Hafshejani A (2017) Some facts on incidence and mortality of cancer in Iran. Iran J Public Health 46(10):1446–1447
Farhood B, Geraily G, Alizadeh A (2018) Incidence and mortality of various cancers in Iran and compare to other countries: a review article. Iran J Public Health 47(3):309
Pitman A, Suleman S (2018) Hyde N. Depression and anxiety in patients with cancer. Bmj, Hodgkiss A, p 361
Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, Abdelalim A, Abdoli A, Abdollahpour I, Abdulle ASM et al (2019) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 5(12):1749–1768
Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A (2005) Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 330(7493):702
Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, Henrichs M, Carnicke CL (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249(6):751–757
Wang Y, Duan Z, Ma Z, Mao Y, Li X, Wilson A, Qin H, Ou J, Peng K, Zhou F et al (2020) Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic. Transl Psychiatry 10(1):263
Tsaras K, Papathanasiou IV, Mitsi D, Veneti A, Kelesi M, Zyga S, Fradelos EC (2018) Assessment of depression and anxiety in breast cancer patients: prevalence and associated factors. Asian Pac J Cancer Prev: APJCP 19(6):1661
Huang X, Zhang T-Z, Li G-H, Liu L, Xu G-Q (2020) Prevalence and correlation of anxiety and depression on the prognosis of postoperative non-small-cell lung cancer patients in North China. Medicine 99(11):e19087
Erim DO, Bensen JT, Mohler JL, Fontham ETH, Song L, Farnan L, Delacroix SE, Peters ES, Erim TN, Chen RC et al (2019) Prevalence and predictors of probable depression in prostate cancer survivors. Cancer 125(19):3418–3427
Pilevarzadeh M, Amirshahi M, Afsargharehbagh R, Rafiemanesh H, Hashemi S-M, Balouchi A (2019) Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis. Breast Cancer Res Treat 176(3):519–533
Hashemi S-M, Rafiemanesh H, Aghamohammadi T, Badakhsh M, Amirshahi M, Sari M, Behnamfar N, Roudini K (2020) Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis. Breast Cancer 27(2):166–178
Seyyed Reza Seyyed T, ParvinRahmati N, Robabeh S (2015) The prevalence of behavioral symptoms of psychological disorders in cancer patients. Thought Behav Clin Psychol 9(36):27–36
Shorofi SA, Nozari-Mirarkolaei F, Arbon P, Bagheri-Nesamie M (2021) Depression and sleep quality among Iranian women with breast cancer. Asian Pac J Cancer Prev 22(11):3433–3440
Nikbakht H, Aminisani N, Hosseini Sr, AsghariJafarabadi M, Ahoei K (2016) Prevalence of anxiety and depression in patients with colorectal cancer in Babol — north of Iran (2008–12). J Gorgan Univ Med Sci 18(1):101–107
Prieto JM, Blanch J, Atala J, Carreras E, Rovira M, Cirera E, Gastó C (2002) Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol 20(7):1907–1917
Colleoni M, Mandala M, Peruzzotti G, Robertson C, Bredart A, Goldhirsch A (2000) Depression and degree of acceptance of adjuvant cytotoxic drugs. The Lancet 356(9238):1326–1327
Yousaf U, Christensen M-L, Engholm G, Storm H (2005) Suicides among Danish cancer patients 1971–1999. Br J Cancer 92(6):995–1000
Ernst M, Wiltink J, Tibubos AN, Brähler E, Schulz A, Wild PS, Burghardt J, Münzel T, König J, Lackner K et al (2019) Linking cancer and mental health in men and women in a representative community sample. J Psychosom Res 124:109760
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71
Lo CK, Mertz D, Loeb M (2014) Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol 14:45
Aminisani N, Nikbakht H, Asghari Jafarabadi M, Shamshirgaran SM (2017) Depression, anxiety, and health related quality of life among colorectal cancer survivors. J Gastrointest Oncol 8(1):81–88
Aminisani N, Nikbakht HA, Shojaie L, Jafari E, Shamshirgaran M (2021) Gender differences in psychological distress in patients with colorectal cancer and its correlates in the Northeast of Iran. J Gastrointest Cancer 53(2):245–252
Hashemi SM, Hormozi M, Allahyari A, Anoushirvani AA, Ameri Z, Ghasemipour S (2020) The prevalence of depression, anxiety, and stress in patients with breast cancer in Southeast Iran in 2019: a cross-sectional study. Oncol Clin Practice 16(3):104–108
Heidarirad f, Yarahmadi M, Heidarirad H, Shafiei M (2018) Evaluation of prevalence of depression and its related factors among women with breast cancer referred to the Radiotherapy Center of Tawhid Hospital of Sanandaj, Iran in 2017. SJNMP 4(2):39–49
Malekian A, Malekian A, Amadzade GH (2007) Anxiety and depression in cancer patients. J Res Behav Sci 5(2):115–119
Mehrabani F, Barati F, Ramezanzade Tabriz E, Bakaeian M, Gholami Chaboki B (2016) Unpleasant emotions (stress, anxiety and depression) and it is relationship with parental bonding and disease and demographic characteristics in patients with breast cancer. Iran J Breast Dis 9(3):42–52
Montazer M, Katani MR, Sefidmooy Azar A, Mobaraki-Asl N, Dorosti A (2019) The relationship between social support and depression in patients with breast cancer. Iran J Breast Dis 12(1):58–66
Motamedi A, Haghighat S, Khalili N, Sadjadian AA, Omidvari S, Mollahoseini F, Sheikhi Mobarakeh Z (2015) The correlation between treatment of depression and quality of life in breast cancer survivors. Iran Quarterly J Breast Dis 8(1):42–48
Amir M, Tahereh M (2014) Ghaleghasemi, Mojtaba G: Survey the anxiety and depression among breast cancer patients referred to the specialized Isfahan hospital of cancer. Iran J Health Syst Res 10(1):39–48
Naseri N, Taleghani F (2018) Social support and depression in iranian cancer patients: the role of demographic variables. J Caring Sci 7(3):143–147
Rajabi Zadeh G, Mansoori S, Shakibi M, Ramazani M (2005) Determination of factors related to depression in cancer patients of the Oncology Ward in Kerman. J Kerman Univ Med Sci 12(2):142–147
Ramezani T (2001) Degree of depression and the need for counseling among women with breast cancer in Kerman Chemotherapeutic Centers. Iran J Psychiatry Clin Psychol 6(4):70–80
Shakeri J, Golshani S, Jalilian E, Farnia V, Nooripour R, Alikhani M, Yaghoobi K (2016) Studying the amount of depression and its role in predicting the quality of life of women with breast cancer. Asian Pac J Cancer Prev : APJCP 17(2):643–646
Shakeri J, Abdoli N, Payande M, Charegar G (2009) The frequency of depression among patients with breast cancer in Kermanshah U.M.S chemotherapy centers in 2007. J Med Counc Iran 27(3):324–328
Tarighat Saber G, Zarei S, Etemadi A, Mohammadi M, Shams G (2006) Assessment of knowledge and satifaction of information given in cancer patients referred to Imam Khomeini Hospital 1382–1383 and its assossiation with anxiety and depression in these patients. Tehran Univ Med J 64(2):165–171
Mols F, Schoormans D, de Hingh I, Oerlemans S, Husson O (2018) Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES Registry: prevalence, predictors, and impact on quality of life. Cancer 124(12):2621–2628
Sun L-M, Liang J-A, Lin C-L, Sun S, Kao C-H (2017) Risk of mood disorders in patients with colorectal cancer. J Affect Disord 218:59–65
Walker J, Hansen CH, Martin P, Symeonides S, Ramessur R, Murray G, Sharpe M (2014) Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data. The Lancet Psychiatry 1(5):343–350
Aryankhesal A, Ghashghaee A, Sardari E, Mahmoudi S, Alihosseini S, Dehnad A, Roohravan Benis M, Gharagozlou D (2019) Prevalence of depression in patients with cancer in Iran: a systematic review and meta-analysis. BMJ Support Palliat Care 12(e4):e518–e525
Krebber AM, Buffart LM, Kleijn G, Riepma IC, de Bree R, Leemans CR, Becker A, Brug J, van Straten A, Cuijpers P et al (2014) Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology 23(2):121–130
Mhaidat NM, Alzoubi KH, Al-Sweedan S, Alhusein BA (2009) Prevalence of depression among cancer patients in Jordan: a national survey. Support Care Cancer 17(11):1403
Aass N, Fosså SD, Dahl AA, Aloe TJ (1997) Prevalence of anxiety and depression in cancer patients seen at the Norwegian Radium Hospital. Eur J Cancer 33(10):1597–1604
Shaheen Al Ahwal M, Al Zaben F, Khalifa DA, Sehlo MG, Ahmad RG, Koenig HG (2015) Depression in patients with colorectal cancer in Saudi Arabia. Psycho-oncology 24(9):1043–1050
Hosaka T (1996) AOKI T: Depression among cancer patients. Psychiatry Clin Neurosci 50(6):309–312
Vodermaier A, Linden W, Siu C (2009) Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 101(21):1464–1488
Massie M (2004) Prevalence of depression in patients with cancer Inst Monogr. J Natl Cancer Inst Monogr (32):57–71
Ramezani T (2001) Amount of depression and the need for counseling in women with breast cancer in chemotherapy centers in Kerman. Andishe va Raftar 6(4):70–70
Ghasempour M, Rahmani A, Davoodi A, Sheikhalipour Z, Ziaeei JE, Abri F (2015) Return to work and its relation to financial distress among iranian cancer survivors. Asian Pac J Cancer Prev 16(6):2257–2261
Deng G, Cassileth BR (2005) Integrative oncology complementary therapies for pain, anxiety, and mood disturbance. CA: Cancer J Clin 55(2):109–116
Akechi T, Ietsugu T, Sukigara M, Okamura H, Nakano T, Akizuki N, Okamura M, Shimizu K, Okuyama T, Furukawa TA (2009) Symptom indicator of severity of depression in cancer patients: a comparison of the DSM-IV criteria with alternative diagnostic criteria. Gen Hosp Psychiatry 31(3):225–232
Trask PC (2004) Assessment of depression in cancer patients. JNCI Monographs 2004(32):80–92
Isfahani P, Arefy M, Shamsaii M (2020) Prevalence of severe depression in Iranian women with breast cancer: a meta-analysis. Depress Res Treat 2020:5871402
Jafari A, Goudarzian AH, Bagheri Nesami M (2018) Depression in women with breast cancer: a systematic review of cross-sectional studies in Iran. Asian Pac J Cancer Prev : APJCP 19(1):1–7
Yang Y-L, Liu L, Wang Y, Wu H, Yang X-S, Wang J-N, Wang L (2013) The prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis. BMC Cancer 13(1):393
Vehling S, Koch U, Ladehoff N, Schön G, Wegscheider K, Heckl U, Weis J, Mehnert A (2012) Prevalence of affective and anxiety disorders in cancer: systematic literature review and meta-analysis. Psychother Psychosom Med Psychol 62(7):249–258
Han CJ, Yang GS, Syrjala K (2020) Symptom experiences in colorectal cancer survivors after cancer treatments: a systematic review and meta-analysis. Cancer Nurs 43(3):E132
Zamani M, Alizadeh-Tabari S (2021) Anxiety and depression prevalence in digestive cancers: a systematic review and meta-analysis. BMJ Support Palliat Care; bmjspcare-2021-003275
Mukherjee A, Mazumder K, Ghoshal S (2018) Impact of different sociodemographic factors on mental health status of female cancer patients receiving chemotherapy for recurrent disease. Indian J Palliat Care 24(4):426
Acknowledgements
This study is the result of research project No. 401000003 approved by the Deputy for Research and Technology, Gerash University of Medical Sciences. We would like to thank the esteemed officials of the center for the financial affords of this study.
Funding
By Deputy for Research and Technology, Gerash University of Medical Sciences (IR) (401000003). This deputy has no role in the study process.
Author information
Authors and Affiliations
Contributions
ND, MM, and HGH contributed to the design; MM statistical analysis, and participated in most of the study steps. ND, MM, and ZR prepared the manuscript. ND, HGH, MM, HA, PSH, and SHSH assisted in designing the study, and helped in the interpretation of the study. All authors have read and approved the content of the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Ethics approval was received from the ethics committee of Deputy of Research and Technology, Gerash University of Medical Sciences (IR.GERUMS.REC.1401.008).
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Darvishi, N., Ghasemi, H., Rahbaralam, Z. et al. The prevalence of depression and anxiety in patients with cancer in Iran: a systematic review and meta-analysis. Support Care Cancer 30, 10273–10284 (2022). https://doi.org/10.1007/s00520-022-07371-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-022-07371-1